These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17919199)

  • 1. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
    Mahé A; Ly F; Aymard G; Dangou JM
    Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
    Raynaud E; Cellier C; Perret JL
    Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of cosmetic skin bleaching in Africa].
    Morand JJ; Ly F; Lightburn E; Mahé A
    Med Trop (Mars); 2007 Dec; 67(6):627-34. PubMed ID: 18300529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous ochronosis and striae atrophicae following the use of bleaching creams.
    Bongiorno MR; Aricò M
    Int J Dermatol; 2005 Feb; 44(2):112-5. PubMed ID: 15689207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reasons for consulting related to skin-bleaching products used by 104 women in Brazzaville].
    Gathse A; Obengui ; Ibara JR
    Bull Soc Pathol Exot; 2005 Dec; 98(5):387-9. PubMed ID: 16425720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of chronic use of skin lightening cosmetics.
    Olumide YM; Akinkugbe AO; Altraide D; Mohammed T; Ahamefule N; Ayanlowo S; Onyekonwu C; Essen N
    Int J Dermatol; 2008 Apr; 47(4):344-53. PubMed ID: 18377596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous squamous cell carcinomas (SCC) associated with cosmetic skin whitening: 8 cases reported in Senegal.
    Ly F; Diousse P; Ndiaye C; Déme A; Diatta BA; Ndiaye MT; Diallo M; Diop A; Kebe AD; Fall F; Kane A
    Ann Dermatol Venereol; 2018 Feb; 145(2):83-88. PubMed ID: 29150154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The widespread use of skin lightening creams in Senegal: a persistent public health problem in West Africa.
    del Giudice P; Yves P
    Int J Dermatol; 2002 Feb; 41(2):69-72. PubMed ID: 11982639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of skin disorders associated with the use of bleaching cosmetics by Lome women].
    Pitche P; Afanou A; Amanga Y; Tchangaï-Walla K
    Sante; 1997; 7(3):161-4. PubMed ID: 9296805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cosmetic use of skin depigmentation products in Africa].
    Del Giudice P; Raynaud E; Mahé A
    Bull Soc Pathol Exot; 2003 Jan; 96(5):389-93. PubMed ID: 15015845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching].
    Sène D; Huong-Boutin DL; Thiollet M; Barete S; Cacoub P; Piette JC
    Rev Med Interne; 2008 Dec; 29(12):1030-3. PubMed ID: 18586357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misuse of Topical Corticosteroids for Cosmetic Purpose in Antananarivo, Madagascar.
    Sendrasoa FA; Ranaivo IM; Andrianarison M; Raharolahy O; Razanakoto NH; Ramarozatovo LS; Rapelanoro Rabenja F
    Biomed Res Int; 2017; 2017():9637083. PubMed ID: 28904977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of suspected illegal skin whitening cosmetics.
    Desmedt B; Van Hoeck E; Rogiers V; Courselle P; De Beer JO; De Paepe K; Deconinck E
    J Pharm Biomed Anal; 2014 Mar; 90():85-91. PubMed ID: 24334193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of the use of skin bleaching cosmetics in two areas in Dakar (Sénégal)].
    Wone I; Tal-Dia A; Diallo OF; Badiane M; Touré K; Diallo I
    Dakar Med; 2000; 45(2):154-7. PubMed ID: 15779174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic complications of the cosmetic use of skin-bleaching products.
    Mahé A; Ly F; Perret JL
    Int J Dermatol; 2005 Oct; 44 Suppl 1():37-8. PubMed ID: 16187958
    [No Abstract]   [Full Text] [Related]  

  • 19. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice.
    Mahé A; Perret JL; Ly F; Fall F; Rault JP; Dumont A
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):183-7. PubMed ID: 17023012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Artificial depigmentation practice of the skin in women of Dakar and analytical study of the cosmetic products used].
    Sylla R; Diouf A; Niane B; Ndiaye B; Guisse MB; Diop A; Ciss M; Ba D
    Dakar Med; 1994; 39(2):223-6. PubMed ID: 8654183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.